Two Siblings with Microcephalic Osteodysplastic Primordial Dwarfism Type II (MOPD II)
PDF
Cite
Share
Request
Poster Presentations
P: 10-10
June 2017

Two Siblings with Microcephalic Osteodysplastic Primordial Dwarfism Type II (MOPD II)

1. Gaziantep Children’S Hospital, Gaziantep, Turkey
2. University Of Edinburgh, Institute Of Genetics And Molecular Medicine, Edinburgh, Uk
No information available.
No information available
PDF
Cite
Share
Request

We aimed to identify the genetic cause of severe short stature and microcephaly in two siblings.

A ten-year-old boy presented with short stature. He was born with a birth weight of 1300 grams (-2.7 SDS) at 34 weeks of gestational age. On physical examination, height was 86 cm (-8.9 SDS), weight 8.4 kg (-7.9 SDS), BMI 11.4 kg/m2 (-5.6 SDS), and head circumference was 37.7 cm (-9.1 SDS). Development was delayed. He started walking at 3 years, speaking with single words at 2 years, and he cannot make sentences yet. He had prominent nose, microcephaly, micrognathia, and microdontia. There were areas of hypo- and hyperpigmentation, cutis marmorata, and few cafe au lait spots on skin. Parents were first-degree cousins. Height of father was 177.5 cm (0.2 SDS) and height of mother was 159 cm (-0.7 SDS); target height was 161.8 cm (-0.2 SDS). His sister presented at 9 months of age and her height was 50.1 cm (-7.1 SDS), weight 3.8 kg (-6.3 SDS), and head circumference was 33.5 cm (-8.1 SDS). She was born with a birth weight of 1135 grams (-2.5 SDS) at 33 weeks of gestational age. Routine laboratory tests, serum levels of free triiodothyronine, free thyroxine, thyroid-stimulating hormone, insulin-like growth factor 1, and insulin-like growth factor binding protein 3 were normal.

Genetic analysis showed homozygous pericentrin mutation c.3109G>T, p.Glu1037 in both siblings. Parents were heterozygous for this mutation.

MPOD II is characterized by severe intrauterine and postnatal growth retardation, microcephaly, and distinctive face; patients with this disorder should be screened for cerebrovascular abnormalities.